{
  "main_header": {
    "sid": 1002898,
    "name": "Ajooni Biotech",
    "stock_name": "Ajooni Biotech",
    "full_name": "Ajooni Biotech Ltd",
    "name_url": "stocks-analysis/ajooni-biotech",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4.54",
    "chg": -0.02,
    "chgp": "-0.44%",
    "dir": -1,
    "prev_price": "4.56",
    "mcapval": "80.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "AJOONI",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE820Y01021",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 343855,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajooni-biotech-1002898-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Ajooni Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ajooni-biotech-fallingrising-3747401",
        "imagepath": "",
        "date": "2025-12-05 01:14:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Ajooni Biotech’s share price decline on 04-Dec is part of a broader downward trend. Over the past week, the stock has dropped 5.59%, significantly underperforming the Sensex’s modest 0.69% decline. The one-month performance is even more stark, with the stock falling 9.70% while the Sensex gained 1.70%. Year-to-date, the stock has plummeted 41.31%, contrasting sharply with the Sensex’s 10.10% rise. This negative momentum extends over longer periods, with the stock down 43.14% in the last year and 37.10% over three years, while the Sensex has delivered positive returns of 6.40% and 39.25% respectively.</p>\n<p>On the day in question, Ajooni Biotech underperformed its sector by 3.27%, and the stock is trading below all major moving average..."
      },
      {
        "title": "How has been the historical performance of Ajooni Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ajooni-biotech-3718922",
        "imagepath": "",
        "date": "2025-11-20 22:55:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue Growth and Profitability Trends</strong></p>\n<p>Over the seven-year period ending March 2025, Ajooni Biotech's net sales have shown a robust increase, rising from ₹39.72 crores in March 2019 to ₹114.69 crores in March 2025. This represents nearly a threefold growth, with particularly notable jumps between March 2021 and March 2025. The total operating income closely mirrors this trend, indicating that other operating income has been negligible in recent years.</p>\n<p>Operating profit before depreciation and interest (PBDIT) excluding other income has also improved, reaching ₹3.68 crores in March 2025 from ₹0.89 crores in March 2019. When factoring in other income, operating profit rose to ₹5.75 crores in the latest fiscal year. However, operating profit margins have remained relative..."
      },
      {
        "title": "Why is Ajooni Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ajooni-biotech-fallingrising-3716539",
        "imagepath": "",
        "date": "2025-11-19 23:56:08",
        "description": "As of 19-Nov, Ajooni Biotech Ltd's stock price is currently at Rs. 4.67, reflecting a decrease of Rs. 0.27, or 5.47%. The stock has recently hit a new 52-week low of Rs. 4.16 and is underperforming its sector by 5.33%. Additionally, Ajooni Biotech is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock's performance over the past week shows a decline of 6.41%, and it has experienced a significant year-to-date drop of 39.90%, contrasting sharply with the Sensex, which has gained 10.18% during the same period. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 10.86% compared to the 5-day average.\n\nIn the broader market context, Ajooni Biotech's recent performance starkly contrasts with the Sensex's positive movement, which has risen by 0.68% over the past week. This divergence suggests that ..."
      },
      {
        "title": "Ajooni Biotech Q2 FY26: Revenue Growth Masks Margin Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/ajooni-biotech-q2-fy26-revenue-growth-masks-margin-pressures-3715392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AjooniBiotech_quaterlyResult_3715392.png",
        "date": "2025-11-14 09:42:15",
        "description": "Ajooni Biotech Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹89.05 crores, reported net profit of ₹0.93 crores for Q2 FY26, marking a 19.23% sequential increase from ₹0.78 crores in Q1 FY26 and a 50.00% year-on-year jump from ₹0.62 crores in Q2 FY25. Despite the profit expansion, the company's stock has struggled significantly, declining 30.23% over the past year whilst the broader Sensex gained 8.53%, resulting in a stark underperformance of 38.76 percentage points. The company's current share price of ₹5.17 reflects persistent concerns about operational efficiency and profitability sustainability."
      },
      {
        "title": "How has been the historical performance of Ajooni Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ajooni-biotech-3699649",
        "imagepath": "",
        "date": "2025-11-13 23:45:02",
        "description": "Answer:\nThe historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years.\n\nBreakdown:\nAjooni Biotech's net sales have increased from 39.72 Cr in Mar'19 to 114.69 Cr in Mar'25, reflecting a strong upward trend. Total operating income has similarly risen, reaching 114.69 Cr in Mar'25 from 40.06 Cr in Mar'19. The company's total expenditure has also grown, but at a slower pace, leading to an operating profit (PBDIT) of 5.75 Cr in Mar'25, up from 0.89 Cr in Mar'19. Profit before tax has improved significantly, reaching 4.33 Cr in Mar'25 compared to 0.47 Cr in Mar'19, while profit after tax has increased to 3.37 Cr from 0.41 Cr in the same period. The company's equity capital has more than doubled from 6.16 Cr in Mar'19 to 34.45 Cr in Mar'25, and total assets have grown from 22.94 Cr to 94.67 Cr. However, the company has seen fluctuations in cash flow, with a ne..."
      },
      {
        "title": "How has been the historical performance of Ajooni Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ajooni-biotech-3608352",
        "imagepath": "",
        "date": "2025-10-09 22:39:07",
        "description": "Answer:\nThe historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025.\n\nBreakdown:\nAjooni Biotech's net sales have increased from 51.04 crore in March 2021 to 114.69 crore in March 2025, reflecting a strong upward trend. Total operating income has similarly risen, reaching 114.69 crore in March 2025, compared to 51.06 crore in March 2021. The company's total expenditure has also grown, amounting to 111.01 crore in March 2025, up from 49.39 crore in March 2021. Operating profit, excluding other income, has improved from 1.67 crore in March 2021 to 3.68 crore in March 2025, while profit before tax has increased from 0.50 crore to 4.33 crore over the same period. Profit after tax has shown a notable rise, reaching 3.37 crore in March 2025, compared to 0.37 crore in March 2021. The company's total assets have expan..."
      },
      {
        "title": "How has been the historical performance of Ajooni Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ajooni-biotech-3580640",
        "imagepath": "",
        "date": "2025-09-29 22:46:29",
        "description": "Answer:\nThe historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years, with the latest figures for March 2025 indicating net sales of 114.69 crore and profit after tax of 3.37 crore.\n\nBreakdown:\nAjooni Biotech has demonstrated a consistent upward trend in net sales, increasing from 39.72 crore in March 2019 to 114.69 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached 114.69 crore in March 2025, up from 40.06 crore in March 2019. The company's operating profit (PBDIT) also improved, showing a rise to 5.75 crore in March 2025 from just 0.89 crore in March 2019. Profit before tax has similarly increased, reaching 4.33 crore in March 2025 compared to 0.47 crore in March 2019. The profit after tax has followed suit, growing to 3.37 crore in March 2025 from 0.41 crore in March 2019. On the balance sheet, total as..."
      },
      {
        "title": "How has been the historical performance of Ajooni Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ajooni-biotech-3561388",
        "imagepath": "",
        "date": "2025-09-23 22:43:23",
        "description": "Answer:\nThe historical performance of Ajooni Biotech shows significant growth in net sales and profit over the years, with the latest figures for March 2025 indicating a net sales of 114.69 crore and a profit after tax of 3.37 crore.\n\nBreakdown:\nAjooni Biotech has demonstrated a consistent upward trend in net sales, increasing from 39.72 crore in March 2019 to 114.69 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached 114.69 crore in March 2025, up from 40.06 crore in March 2019. The company's total expenditure also rose significantly, from 39.17 crore in March 2019 to 111.01 crore in March 2025, reflecting increased operational costs. Operating profit, excluding other income, improved from 0.89 crore in March 2019 to 3.68 crore in March 2025, while profit before tax rose from 0.47 crore to 4.33 crore in the same period. The profit after tax saw a notable incre..."
      },
      {
        "title": "How has been the historical performance of Ajooni Biotech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-ajooni-biotech-3522166",
        "imagepath": "",
        "date": "2025-09-16 22:42:44",
        "description": "Answer:\nThe historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years, particularly from 2021 to 2025.\n\nBreakdown:\nAjooni Biotech's net sales have increased from 51.04 Cr in March 2021 to 114.69 Cr in March 2025, indicating a strong upward trend. Total operating income followed a similar trajectory, rising from 40.09 Cr in March 2020 to 114.69 Cr in March 2025. The company's total expenditure also grew, reaching 111.01 Cr in March 2025 from 38.93 Cr in March 2020. Operating profit (PBDIT) has shown fluctuations, peaking at 5.75 Cr in March 2025, while profit before tax increased significantly from 0.48 Cr in March 2020 to 4.33 Cr in March 2025. Profit after tax also saw a substantial rise, reaching 3.37 Cr in March 2025 compared to 0.35 Cr in March 2020. The company's total assets grew from 22.94 Cr in March 2020 to 94.67 Cr in March 2025, while total li..."
      }
    ],
    "total": 94,
    "sid": "1002898",
    "stock_news_url": "https://www.marketsmojo.com/news/ajooni-biotech-1002898"
  },
  "announcements": [
    {
      "details": "Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Ajooni Biotech Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": "Ajooni Biotech Limited with respect to announcement dated 14-Oct-2019, that the Board of Directors in their meeting held on October 14, 2019 has considered and approved the resignation of Ms. Kanika Sapra, Company Secretary and Compliance Officer of the Company. On basis of above the Company is required to clarify following: 1. Date of resignation of Ms. Kanika Sapra. The response of the Company is awaited.",
      "source": "NSE",
      "caption": "Ajooni Biotech Limited - Clarification",
      "datetime": "23-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>2:10</strong> stock split, ex-date: 07 Oct 22",
          "dt": "2022-10-07",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>1:9</strong> bonus issue, ex-date: 10 Mar 21",
          "dt": "2021-03-10",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Ajooni Biotech Ltd has announced <strong>1:1</strong> rights issue, ex-date: 07 May 24",
          "dt": "2024-05-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Why is Ajooni Biotech falling/rising?

2025-12-05 01:14:11

Recent Price Movement and Market Context

Ajooni Biotech’s share price decline on 04-Dec is part of a broader downward trend. Over the past week, the stock has dropped 5.59%, significantly underperforming the Sensex’s modest 0.69% decline. The one-month performance is even more stark, with the stock falling 9.70% while the Sensex gained 1.70%. Year-to-date, the stock has plummeted 41.31%, contrasting sharply with the Sensex’s 10.10% rise. This negative momentum extends over longer periods, with the stock down 43.14% in the last year and 37.10% over three years, while the Sensex has delivered positive returns of 6.40% and 39.25% respectively.

On the day in question, Ajooni Biotech underperformed its sector by 3.27%, and the stock is trading below all major moving average...

Read More

How has been the historical performance of Ajooni Biotech?

2025-11-20 22:55:46

Revenue Growth and Profitability Trends

Over the seven-year period ending March 2025, Ajooni Biotech's net sales have shown a robust increase, rising from ₹39.72 crores in March 2019 to ₹114.69 crores in March 2025. This represents nearly a threefold growth, with particularly notable jumps between March 2021 and March 2025. The total operating income closely mirrors this trend, indicating that other operating income has been negligible in recent years.

Operating profit before depreciation and interest (PBDIT) excluding other income has also improved, reaching ₹3.68 crores in March 2025 from ₹0.89 crores in March 2019. When factoring in other income, operating profit rose to ₹5.75 crores in the latest fiscal year. However, operating profit margins have remained relative...

Read More

Why is Ajooni Biotech falling/rising?

2025-11-19 23:56:08

As of 19-Nov, Ajooni Biotech Ltd's stock price is currently at Rs. 4.67, reflecting a decrease of Rs. 0.27, or 5.47%. The stock has recently hit a new 52-week low of Rs. 4.16 and is underperforming its sector by 5.33%. Additionally, Ajooni Biotech is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock's performance over the past week shows a decline of 6.41%, and it has experienced a significant year-to-date drop of 39.90%, contrasting sharply with the Sensex, which has gained 10.18% during the same period. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 10.86% compared to the 5-day average. In the broader market context, Ajooni Biotech's recent performance starkly contrasts with the Sensex's positive movement, which has risen by 0.68% over the past week. This divergence suggests that ...

Read More

Ajooni Biotech Q2 FY26: Revenue Growth Masks Margin Pressures

2025-11-14 09:42:15

Ajooni Biotech Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹89.05 crores, reported net profit of ₹0.93 crores for Q2 FY26, marking a 19.23% sequential increase from ₹0.78 crores in Q1 FY26 and a 50.00% year-on-year jump from ₹0.62 crores in Q2 FY25. Despite the profit expansion, the company's stock has struggled significantly, declining 30.23% over the past year whilst the broader Sensex gained 8.53%, resulting in a stark underperformance of 38.76 percentage points. The company's current share price of ₹5.17 reflects persistent concerns about operational efficiency and profitability sustainability.

Read More

How has been the historical performance of Ajooni Biotech?

2025-11-13 23:45:02

Answer: The historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years. Breakdown: Ajooni Biotech's net sales have increased from 39.72 Cr in Mar'19 to 114.69 Cr in Mar'25, reflecting a strong upward trend. Total operating income has similarly risen, reaching 114.69 Cr in Mar'25 from 40.06 Cr in Mar'19. The company's total expenditure has also grown, but at a slower pace, leading to an operating profit (PBDIT) of 5.75 Cr in Mar'25, up from 0.89 Cr in Mar'19. Profit before tax has improved significantly, reaching 4.33 Cr in Mar'25 compared to 0.47 Cr in Mar'19, while profit after tax has increased to 3.37 Cr from 0.41 Cr in the same period. The company's equity capital has more than doubled from 6.16 Cr in Mar'19 to 34.45 Cr in Mar'25, and total assets have grown from 22.94 Cr to 94.67 Cr. However, the company has seen fluctuations in cash flow, with a ne...

Read More

How has been the historical performance of Ajooni Biotech?

2025-10-09 22:39:07

Answer: The historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025. Breakdown: Ajooni Biotech's net sales have increased from 51.04 crore in March 2021 to 114.69 crore in March 2025, reflecting a strong upward trend. Total operating income has similarly risen, reaching 114.69 crore in March 2025, compared to 51.06 crore in March 2021. The company's total expenditure has also grown, amounting to 111.01 crore in March 2025, up from 49.39 crore in March 2021. Operating profit, excluding other income, has improved from 1.67 crore in March 2021 to 3.68 crore in March 2025, while profit before tax has increased from 0.50 crore to 4.33 crore over the same period. Profit after tax has shown a notable rise, reaching 3.37 crore in March 2025, compared to 0.37 crore in March 2021. The company's total assets have expan...

Read More

How has been the historical performance of Ajooni Biotech?

2025-09-29 22:46:29

Answer: The historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years, with the latest figures for March 2025 indicating net sales of 114.69 crore and profit after tax of 3.37 crore. Breakdown: Ajooni Biotech has demonstrated a consistent upward trend in net sales, increasing from 39.72 crore in March 2019 to 114.69 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached 114.69 crore in March 2025, up from 40.06 crore in March 2019. The company's operating profit (PBDIT) also improved, showing a rise to 5.75 crore in March 2025 from just 0.89 crore in March 2019. Profit before tax has similarly increased, reaching 4.33 crore in March 2025 compared to 0.47 crore in March 2019. The profit after tax has followed suit, growing to 3.37 crore in March 2025 from 0.41 crore in March 2019. On the balance sheet, total as...

Read More

How has been the historical performance of Ajooni Biotech?

2025-09-23 22:43:23

Answer: The historical performance of Ajooni Biotech shows significant growth in net sales and profit over the years, with the latest figures for March 2025 indicating a net sales of 114.69 crore and a profit after tax of 3.37 crore. Breakdown: Ajooni Biotech has demonstrated a consistent upward trend in net sales, increasing from 39.72 crore in March 2019 to 114.69 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached 114.69 crore in March 2025, up from 40.06 crore in March 2019. The company's total expenditure also rose significantly, from 39.17 crore in March 2019 to 111.01 crore in March 2025, reflecting increased operational costs. Operating profit, excluding other income, improved from 0.89 crore in March 2019 to 3.68 crore in March 2025, while profit before tax rose from 0.47 crore to 4.33 crore in the same period. The profit after tax saw a notable incre...

Read More

How has been the historical performance of Ajooni Biotech?

2025-09-16 22:42:44

Answer: The historical performance of Ajooni Biotech shows significant growth in net sales and profitability over the years, particularly from 2021 to 2025. Breakdown: Ajooni Biotech's net sales have increased from 51.04 Cr in March 2021 to 114.69 Cr in March 2025, indicating a strong upward trend. Total operating income followed a similar trajectory, rising from 40.09 Cr in March 2020 to 114.69 Cr in March 2025. The company's total expenditure also grew, reaching 111.01 Cr in March 2025 from 38.93 Cr in March 2020. Operating profit (PBDIT) has shown fluctuations, peaking at 5.75 Cr in March 2025, while profit before tax increased significantly from 0.48 Cr in March 2020 to 4.33 Cr in March 2025. Profit after tax also saw a substantial rise, reaching 3.37 Cr in March 2025 compared to 0.35 Cr in March 2020. The company's total assets grew from 22.94 Cr in March 2020 to 94.67 Cr in March 2025, while total li...

Read More

View All News